Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Magnus Ohman

Showing results (41-50 of 511) with videos related to

Pageof 52
Sort By:
Annals of Emergency Medicine|January 15, 2008
Hypertension with acute coronary syndrome and heart failureDeborah B Diercks, E Magnus Ohman
The Canadian Journal of Cardiology|October 9, 2003
The everlasting effect of primary percutaneous coronary intervention--even after transport?Mauricio G Cohen, E Magnus Ohman
Circulation|August 6, 2008
What do you need to know before performing a percutaneous coronary intervention?Matthew A Cavender, E Magnus Ohman
JACC. Heart Failure|June 2, 2018
Revascularization for Heart Failure: Can We Do Better?E Magnus Ohman, Eric J Velazquez
JAMA Cardiology|December 9, 2020
Risk Stratification Science Goes to a New LevelRobert A Harrington, E Magnus Ohman
Journal of the American College of Cardiology|January 22, 2021
Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?E Magnus Ohman, Michael G Nanna
JACC. Cardiovascular Interventions|May 21, 2021
Left Ventricular Support for the Management of Cardiogenic Shock: Sooner May Be BetterE Magnus Ohman, Brittany A Zwischenberger, Holger Thiele
Expert Opinion on Pharmacotherapy|July 17, 2008
Major bleeding: management and risk reduction in acute coronary syndromesMatthew A Cavender, Sunil V Rao, E Magnus Ohman
Journal of the American College of Cardiology|March 20, 2003
Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromesL Kristin Newby, Britta U Goldmann, E Magnus Ohman
Circulation. Cardiovascular Interventions|February 5, 2021
Therapeutic Approaches for the No-Option Refractory Angina PatientThomas J Povsic, Timothy D Henry, E Magnus Ohman
Pageof 52

Showing results (41-50 of 511) with videos related to

Sort By:
Pageof 52
Annals of Emergency Medicine|January 15, 2008
Hypertension with acute coronary syndrome and heart failureDeborah B Diercks, E Magnus Ohman
The Canadian Journal of Cardiology|October 9, 2003
The everlasting effect of primary percutaneous coronary intervention--even after transport?Mauricio G Cohen, E Magnus Ohman
Circulation|August 6, 2008
What do you need to know before performing a percutaneous coronary intervention?Matthew A Cavender, E Magnus Ohman
JACC. Heart Failure|June 2, 2018
Revascularization for Heart Failure: Can We Do Better?E Magnus Ohman, Eric J Velazquez
JAMA Cardiology|December 9, 2020
Risk Stratification Science Goes to a New LevelRobert A Harrington, E Magnus Ohman
Journal of the American College of Cardiology|January 22, 2021
Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?E Magnus Ohman, Michael G Nanna
JACC. Cardiovascular Interventions|May 21, 2021
Left Ventricular Support for the Management of Cardiogenic Shock: Sooner May Be BetterE Magnus Ohman, Brittany A Zwischenberger, Holger Thiele
Expert Opinion on Pharmacotherapy|July 17, 2008
Major bleeding: management and risk reduction in acute coronary syndromesMatthew A Cavender, Sunil V Rao, E Magnus Ohman
Journal of the American College of Cardiology|March 20, 2003
Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromesL Kristin Newby, Britta U Goldmann, E Magnus Ohman
Circulation. Cardiovascular Interventions|February 5, 2021
Therapeutic Approaches for the No-Option Refractory Angina PatientThomas J Povsic, Timothy D Henry, E Magnus Ohman
Pageof 52